2020 saw over 3,500 research papers released that look into cannabis and its effects, making it a record year for the plant.
As we've discussed here many times at The Green Fund, research into cannabis remains one of the keys to pushing the industry toward the mainstream and into legalization.
As Australia's Therapeutic Goods Administration (TGA) outlined in 2019, "in many cases, there are very limited data from which to draw specific recommendations for treatment."
Given that cannabis remains a Schedule I substance in the U.S. due to its perceived "lack of accepted medical uses," one of the linchpins of widespread cannabis legalization is through a growing body of research surrounding the medical uses of cannabis and its derivatives.
Thankfully, it appears the tides are …